Ask questions and gain insights about this stock now with Rize AI
PACB logo

Pacific Biosciences of California, Inc.

PACB

Stock Analysis

$1.64

+0.00 (+0.00%)• Live

Pacific Biosciences of California, Inc. Analysis Dashboard - Stock Analysis and Financial Metrics

Historical Prices

for Pacific Biosciences of California, Inc.

Key Financial Metrics

for Pacific Biosciences of California, Inc.

2024 FY
P/E Ratio
-0.52
Revenue Growth
-23.19%
EPS Growth
+6.61%
Market Cap
$0.35B
Dividend Yield
0.00%
Debt/Equity
7.63
ROIC
-99.27%
FCF Yield
-52.61%
View additional metrics

Valuation

P/B Ratio3.76
EV/Sales6.49

Financial Health

Current Ratio6.68
Return on Assets-125.32%

Analyst Recommendations

for Pacific Biosciences of California, Inc.

18 analysts
Consensus: Buy

About

for Pacific Biosciences of California, Inc.

Company Details

for Pacific Biosciences of California, Inc.

Sector

Healthcare

Industry

Medical - Devices

CEO

Christian O. Henry

Employees

575

Market Cap

492.61M

Exchange

NASDAQ Global Select

IPO Date

October 27, 2010

CIK

0001299130

ISIN

US69404D1081

CUSIP

69404D108

Country

US

Balance Sheet

for Pacific Biosciences of California, Inc.

Cash Flow Statement

for Pacific Biosciences of California, Inc.

Income Statement

for Pacific Biosciences of California, Inc.

Rize ist ein KI-gestütztes Investment-Research-Terminal, das eine umfassende Aktienanalyse und Einblicke über ein intuitives Dashboard bietet.

News

No news available at the moment.